We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Difference Between Acupuncture and Far-infrared Ray Illumination at CV12 Acupoint

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01339715
Recruitment Status : Completed
First Posted : April 21, 2011
Last Update Posted : July 23, 2012
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of the study was to investigate the changes of Ryodoraku value at 12 source acupoints, and heart rate viability (HRV) when acupuncture or far-infrared ray illumination applied to CV12 acupoint.

Condition or disease Intervention/treatment
Reaction of Autonomic Nervous System Reaction of Acupuncture Reaction of Far Infrared Ray Procedure: acupuncture and far-infrared ray

Detailed Description:
Acupuncture and far-infrared ray illumination at CV12 acupoint have been widely used to treat many diseases in clinic. To our knowledge, the report is about the different reaction on autonomic nervous system between acupuncture and far-infrared illumination is very rare until now.Therefore,the study was to investigate the different changes on autonomic nervous system from Ryodoraku value at 12 source acupoints and heart rate viability (HRV) when acupuncture or far-infrared ray illumination applied to CV12 acupoint.

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 25 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Participant)
Primary Purpose: Basic Science
Official Title: From the Changes of Ryodoraku Value at 12 Source Acupoints, and Heart Rate Viability to Explain the Difference Between Acupuncture and Far-infrared Ray Illumination at CV12(Zhongwan)Acupoint
Study Start Date : April 2011
Primary Completion Date : March 2012
Study Completion Date : March 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Acupuncture
U.S. FDA Resources

Arms and Interventions

Intervention Details:
    Procedure: acupuncture and far-infrared ray
    During experimental phase,inserting the needle of acupuncture into CV12 acupoint or using far-infrared ray to illuminate on CV12 20 minutes.

Outcome Measures

Primary Outcome Measures :
  1. From the changes of Ryodoraku value at 12 source acupoints, and heart rate viability to measure the difference [ Time Frame: Each period was 20 min in duration. The Ryodoraku value of 12 source acupoints were measured, and 5-min HRV was recorded at the end of each period. ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy adult volunteers, male or female, ages between 20 and 40
  • Neurological and physical examination without abnormal functions
  • Far-infrared ray illumination without allergic reaction and contra- indication
  • The participants were explained the objective of the study, agreed to accept the test and signed a letter of consent

Exclusion Criteria:

  • People less than 20 years of age or more than 40 years
  • Women in pregnant or lactating
  • People with mental or behavioral anomalies could not follow the researchers
  • People with pacemakers
  • People suffered from serious diseases such as myocardial infarction , heart failure, serious arrhythmia, hypertension, diabetes, autoimmune disease, chronic obstructive pulmonary diseases, and kidney failure, liver cirrhosis and cancer
  • People accepted acupuncture and moxibustion in a week, or were taking any drugs for treatment
  • People suffered from limb edema and serious skin diseases
  • People with excessive obesity (body mass index, BMI>30)
  • People did not sign a letter of consent
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01339715


Locations
Taiwan
China Medical University Hospital
Taichung, Taiwan, 404
Sponsors and Collaborators
China Medical University Hospital
Investigators
Study Chair: Ching-Liang Hsieh, professor China Medical University Hospital
More Information

Responsible Party: China Medical University Hospital
ClinicalTrials.gov Identifier: NCT01339715     History of Changes
Other Study ID Numbers: DMR100-IRB-032
First Posted: April 21, 2011    Key Record Dates
Last Update Posted: July 23, 2012
Last Verified: July 2012

Keywords provided by China Medical University Hospital:
Ryodoraku
Heart Rate Variability
Traditional medicine
Autonomic Nervous System
Acupuncture
Far Infrared Ray
CV12 Acupoint